Peptide Library

Not FDA-approved

Bones & muscles

MK-677 (ibutamoren)

Evidence

Limited human data

Class

Oral ghrelin receptor agonist (small molecule)

/

MK-677 (ibutamoren)

KEY TAKEAWAY

MK-677, also called ibutamoren, is a small molecule rather than a peptide. It mimics ghrelin and is taken by mouth. MK-677 is not FDA-approved. Trials showed it raised IGF-1 and lean mass, but it also increased blood sugar and fluid retention.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Oral ghrelin receptor agonist (small molecule)

Main uses

Studied for growth hormone deficiency, frailty and muscle loss; sold online for performance

Key fact

MK-677 is not FDA-approved. Trials showed it raised IGF-1 and lean mass, but it also increased blood sugar and fluid retention.

Route

Oral capsule or liquid once a day

Evidence strength

Limited human data

What it is

What it is

MK-677, also called ibutamoren, is a small molecule rather than a peptide. It mimics ghrelin and is taken by mouth.

How it works

How it works

It activates the ghrelin receptor, which raises growth hormone and IGF-1 levels.

Regulatory status

Regulatory status

MK-677 is not FDA-approved. Trials showed it raised IGF-1 and lean mass, but it also increased blood sugar and fluid retention.

What it is used for

What it is used for

Studied for growth hormone deficiency, frailty and muscle loss; sold online for performance.

Side effects and risks

Side effects and risks

Increased appetite, water retention, higher fasting blood sugar and insulin resistance are the main concerns.

Citations

Citations

MK-677 (ibutamoren): see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo